Chimerix

Licensing Opportunities

Chimerix has amassed an unusual breadth of assets with considerable potential in antiviral innovation, including our Lipid-Antiviral-Conjugate Technology and the Chimerix Chemical Library. The combination of our team’s internal antiviral product expertise with a number of internally-generated leads against several important viruses allows us the flexibility to pursue out-licensing or co-development partners for our emergent antiviral medicines.

As our products demonstrate clinical proof-of-concept, we will seek out strategic collaborations and partnerships with pharmaceutical companies for late-stage clinical development and marketing.

For more information, please contact busdev@chimerix.com